» Articles » PMID: 35013316

Association of Mutation Signature Effectuating Processes with Mutation Hotspots in Driver Genes and Non-coding Regions

Overview
Journal Nat Commun
Specialty Biology
Date 2022 Jan 11
PMID 35013316
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer driving mutations are difficult to identify especially in the non-coding part of the genome. Here, we present sigDriver, an algorithm dedicated to call driver mutations. Using 3813 whole-genome sequenced tumors from International Cancer Genome Consortium, The Cancer Genome Atlas Program, and a childhood pan-cancer cohort, we employ mutational signatures based on single-base substitution in the context of tri- and penta-nucleotide motifs for hotspot discovery. Knowledge-based annotations on mutational hotspots reveal enrichment in coding regions and regulatory elements for 6 mutational signatures, including APOBEC and somatic hypermutation signatures. APOBEC activity is associated with 32 hotspots of which 11 are known and 11 are putative regulatory drivers. Somatic single nucleotide variants clusters detected at hypermutation-associated hotspots are distinct from translocation or gene amplifications. Patients carrying APOBEC induced PIK3CA driver mutations show lower occurrence of signature SBS39. In summary, sigDriver uncovers mutational processes associated with known and putative tumor drivers and hotspots particularly in the non-coding regions of the genome.

Citing Articles

The theory of massively repeated evolution and full identifications of cancer-driving nucleotides (CDNs).

Zhang L, Deng T, Liufu Z, Liu X, Chen B, Hu Z Elife. 2024; 13.

PMID: 39688960 PMC: 11651657. DOI: 10.7554/eLife.99340.


Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature.

Nakauma-Gonzalez J, Rijnders M, Noordsij M, Martens J, van der Veldt A, Lolkema M Cell Genom. 2024; 4(4):100528.

PMID: 38552621 PMC: 11019362. DOI: 10.1016/j.xgen.2024.100528.


The Crucial Findings Derived from the Special Issue "Inside Cancer Genomics: From Structure to Therapy".

Barresi V Cancers (Basel). 2023; 15(13).

PMID: 37444598 PMC: 10341065. DOI: 10.3390/cancers15133488.


Influence network model uncovers relations between biological processes and mutational signatures.

Amgalan B, Wojtowicz D, Kim Y, Przytycka T Genome Med. 2023; 15(1):15.

PMID: 36879282 PMC: 9987115. DOI: 10.1186/s13073-023-01162-x.


Cervical cancer heterogeneity: a constant battle against viruses and drugs.

Sun Q, Wang L, Zhang C, Hong Z, Han Z Biomark Res. 2022; 10(1):85.

PMID: 36397138 PMC: 9670454. DOI: 10.1186/s40364-022-00428-7.


References
1.
Sondka Z, Bamford S, Cole C, Ward S, Dunham I, Forbes S . The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat Rev Cancer. 2018; 18(11):696-705. PMC: 6450507. DOI: 10.1038/s41568-018-0060-1. View

2.
Alexandrov L, Ju Y, Haase K, Van Loo P, Martincorena I, Nik-Zainal S . Mutational signatures associated with tobacco smoking in human cancer. Science. 2016; 354(6312):618-622. PMC: 6141049. DOI: 10.1126/science.aag0299. View

3.
. Pan-cancer analysis of whole genomes. Nature. 2020; 578(7793):82-93. PMC: 7025898. DOI: 10.1038/s41586-020-1969-6. View

4.
Jiang L, Zheng J, Kwan J, Dai S, Li C, Li M . WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts. Nucleic Acids Res. 2019; 47(16):e96. PMC: 6895256. DOI: 10.1093/nar/gkz566. View

5.
Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View